What is the current Urea Cycle Disorders (UCD) Treatment market size?

The UCD Treatment market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the UCD Treatment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the UCD Treatment market?

Key drivers include rising awareness and diagnosis rates of Urea Cycle Disorders.

What are the major challenges facing the UCD Treatment market?

Challenges include high treatment costs and limited availability of effective therapies.

Which regions are leading the UCD Treatment market?

North America and Europe are currently leading the market due to high awareness and diagnosis rates.

Who are the top companies in the UCD Treatment market?

Top companies include leading pharmaceutical firms and specialty treatment providers.

What future opportunities exist in the UCD Treatment market?

Future opportunities include the development of new therapies and expanding treatment access globally.

How will technology impact the UCD Treatment market?

Technology will improve diagnosis rates and treatment outcomes through advanced diagnostic tools and therapies.

What is the current regulatory landscape for the UCD Treatment market?

The regulatory landscape is evolving with increasing support for rare disease treatment development and approval.

What is the future outlook for the UCD Treatment market?

The future outlook is positive with growing demand and increasing investment in treatment development.

Urea Cycle Disorders (UCD) Treatment Market Growth Drivers & Forecast 2033

Urea Cycle Disorders (UCD) Treatment by Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Types (Amino Acid Formulas, Phenylbutyrate, Sodium Benzoate, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Urea Cycle Disorders (UCD) Treatment Market Size | CAGR 8.9 Forecast 2033

Urea Cycle Disorders (UCD) Treatment Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Urea Cycle Disorders (UCD) Treatment Market Overview

The Urea Cycle Disorders (UCD) Treatment market is a critical segment of the healthcare industry, focusing on the diagnosis, treatment, and management of urea cycle disorders. As the global Urea Cycle Disorders (UCD) Treatment market size is estimated to be around $1.4 billion, the growth outlook and market forecast indicate a promising industry expansion driven by advancements in medical technology, increasing awareness, and improving healthcare infrastructure. The scope of this market encompasses various treatment options, including medications, dietary supplements, and gene therapy, catering to the diverse needs of UCD patients. With a projected Compound Annual Growth Rate (CAGR) of 8.5%, the market is poised for significant growth, influenced by macro drivers such as regulatory support, competitive intensity, and consumer behavior.

Loading chart…

The Urea Cycle Disorders (UCD) Treatment market is shaped by key forces such as technology shifts, regulatory frameworks, and supply-chain dynamics. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing awareness and improving healthcare infrastructure. As the market continues to evolve, it is essential for stakeholders to stay informed about the latest trends, growth drivers, and competitive landscape to make strategic decisions and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.44 billion
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Horizon Therapeutics; Eurocept BV; Recordati Rare Diseases Inc.; Synlogic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Urea Cycle Disorders (UCD) Treatment market is experiencing significant transformations, driven by various factors that impact its Urea Cycle Disorders (UCD) Treatment market size and growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in diagnostic technologies have improved the detection rates of Urea Cycle Disorders, leading to an increase in the diagnosed population and subsequently driving the demand for Urea Cycle Disorders (UCD) Treatment market solutions.

Government initiatives and awareness campaigns about rare genetic disorders, including UCD, have enhanced the focus on these conditions, contributing to the growth of the Urea Cycle Disorders (UCD) Treatment market size.

Restraints2 items

The high cost of treatments, particularly for rare diseases like UCD, poses a significant barrier to access, limiting the growth forecast of the Urea Cycle Disorders (UCD) Treatment market.

The lack of standardized protocols for UCD management and treatment across different regions hinders the uniform growth of the Urea Cycle Disorders (UCD) Treatment market.

Opportunities2 items

The emergence of novel therapeutic approaches, including gene therapies and small molecule treatments, presents opportunities for innovation and expansion in the Urea Cycle Disorders (UCD) Treatment market.

Collaborations between pharmaceutical companies, research institutions, and patient advocacy groups can accelerate the development of new treatments, enhancing the Urea Cycle Disorders (UCD) Treatment market size and improving patient outcomes.

Challenges2 items

The rare nature of UCD poses challenges in conducting clinical trials, due to the small patient population, which can slow down the approval and launch of new treatments in the Urea Cycle Disorders (UCD) Treatment market.

Ensuring the long-term efficacy and safety of treatments, as well as managing the complex side effects associated with some therapies, remains a significant challenge in the Urea Cycle Disorders (UCD) Treatment market.

Market Segmentation

Loading chart…

The Urea Cycle Disorders (UCD) Treatment market can be segmented based on Application, which includes diagnosis and treatment of UCD. The diagnosis segment contributes to the overall market size by providing genetic testing and medical imaging services to identify UCD. The treatment segment, on the other hand, contributes by providing medications and dietary supplements to manage UCD symptoms. Understanding the Urea Cycle Disorders (UCD) Treatment segmentation is crucial to develop effective marketing strategies and product development plans.

Another way to segment the Urea Cycle Disorders (UCD) Treatment market is by Types, which includes OTC and prescription medications. The OTC segment includes ammonia-scavenging medications and dietary supplements, while the prescription segment includes medications that require a doctor's prescription. The types segment contributes to the overall market size by providing a range of treatment options for UCD patients. The market taxonomy of UCD treatment is complex and requires a thorough understanding of the different segments and sub-segments.

Urea Cycle Disorders (UCD) Treatment Segmentation Breakdown9 items

Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Types

Amino Acid Formulas

Phenylbutyrate

Sodium Benzoate

Others

Regional Insights

Loading chart…

The Urea Cycle Disorders (UCD) Treatment market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of novel therapeutics, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers comprise policies supporting rare disease treatment, a strong ecosystem, and growing adoption of orphan drugs. Asia Pacific's growth is fueled by expanding infrastructure, increasing investments, and rising demographics. Latin America's and Middle East & Africa's growth are driven by improving infrastructure, growing adoption, and increasing investments in healthcare.

The regional forecast indicates that North America will maintain its lead, while Asia Pacific will experience the highest growth rate. Understanding these regional dynamics is crucial for stakeholders to navigate the Urea Cycle Disorders (UCD) Treatment market effectively and capitalize on emerging opportunities.

Competitive Landscape

The Urea Cycle Disorders (UCD) Treatment market is moderately consolidated, driven by a mix of global players and local companies. The Urea Cycle Disorders (UCD) Treatment competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on distribution and pricing strategies.

Companies in the UCD Treatment market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Horizon Therapeutics: regional expansion

Eurocept BV: innovation pipeline

Recordati Rare Diseases Inc.: premium pricing

Synlogic: local manufacturing

Horizon Therapeutics: vertical integration

Eurocept BV: OEM tie-ups

Key Urea Cycle Disorders (UCD) Treatment Companies4 items

Horizon Therapeutics

Eurocept BV

Recordati Rare Diseases Inc.

Synlogic

Market Ecosystem

The Urea Cycle Disorders (UCD) Treatment ecosystem spans multiple stakeholders, from upstream technology providers and suppliers to downstream channels and end users. The ecosystem is characterized by a complex interplay of value creation and capture, with various participants influencing the development, delivery, and adoption of UCD treatments. The ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where treatments are manufactured and integrated; and downstream, where treatments are distributed and delivered to end users.

Raw material/component suppliers — provide inputs for treatment development

Technology providers — develop innovative UCD treatments

OEMs / manufacturers — produce UCD treatments

Distributors / channel partners — deliver treatments to healthcare providers

Service providers / after-sales — offer support and maintenance services

End users / buyers — receive UCD treatments

Regulators/standards bodies — oversee treatment approvals and compliance

The flow of value in the Urea Cycle Disorders (UCD) Treatment ecosystem is influenced by various control points, including regulatory approvals, reimbursement policies, and partnerships between stakeholders. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Furthermore, switching costs, interoperability requirements, and regional differences in treatment adoption and availability can affect the ecosystem's dynamics. As the ecosystem continues to evolve, understanding these complexities is crucial for navigating the Urea Cycle Disorders (UCD) Treatment ecosystem and conducting a thorough value chain analysis.

Recent Industry Insights

The Urea Cycle Disorders (UCD) Treatment industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships and collaborations have been formed to accelerate the development of innovative treatments. For instance, leading pharmaceutical companies have joined forces to advance gene therapies and other novel approaches for UCD.

Furthermore, the industry has seen strategic mergers and acquisitions, as well as product launches that have expanded the treatment landscape for UCD patients. Regulatory bodies have also implemented changes to support the development and approval of new therapies, driving growth in the UCD treatment market. These advancements are expected to shape the future of the Urea Cycle Disorders (UCD) Treatment industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Urea Cycle Disorders (UCD) Treatment market outlook. The market attractiveness is moderate due to the growing prevalence of UCD and the increasing awareness of available treatments. The competitive intensity is relatively low, with few players dominating the market. The long-term outlook is promising, driven by innovation in treatment options and rising demand for effective therapies.

The innovation landscape is characterized by ongoing research into novel therapies, including gene therapies and small molecule treatments. However, the demand-supply balance is a concern, with a shortage of effective treatments for certain UCD types. Key risk factors include regulatory challenges and high development costs. Despite these risks, the Urea Cycle Disorders (UCD) Treatment market outlook remains positive, with opportunities for growth and investment in this critical therapeutic area.

11 items

1. Executive Summary

2. Urea Cycle Disorders (UCD) Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Urea Cycle Disorders (UCD) Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Urea Cycle Disorders (UCD) Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

6.2. Global Urea Cycle Disorders (UCD) Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Amino Acid Formulas

6.2.2. Phenylbutyrate

6.2.3. Sodium Benzoate

6.2.4. Others

6.3. Global Urea Cycle Disorders (UCD) Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Urea Cycle Disorders (UCD) Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Urea Cycle Disorders (UCD) Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Urea Cycle Disorders (UCD) Treatment Market Competition by Key Manufacturers

8.1. Global Urea Cycle Disorders (UCD) Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Urea Cycle Disorders (UCD) Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Horizon Therapeutics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Eurocept BV

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Recordati Rare Diseases Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Synlogic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Urea Cycle Disorders (UCD) Treatment Market

Figure 4: Global Urea Cycle Disorders (UCD) Treatment Market: Drivers

Figure 5: Global Urea Cycle Disorders (UCD) Treatment Market: Challenges

Figure 6: Global Urea Cycle Disorders (UCD) Treatment Market: Trends

Figure 7: Global Urea Cycle Disorders (UCD) Treatment Market: Opportunity

Figure 8: Global Urea Cycle Disorders (UCD) Treatment Market: Restraint

Figure 9: Global Urea Cycle Disorders (UCD) Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Urea Cycle Disorders (UCD) Treatment Market Value (USD Million) By Region

Figure 15: Global Urea Cycle Disorders (UCD) Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Urea Cycle Disorders (UCD) Treatment Market Value (USD Million) By Region

Figure 23: Global Urea Cycle Disorders (UCD) Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

61 items

Table 1: Market Segmentation Analysis

Table 2: Global Urea Cycle Disorders (UCD) Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Urea Cycle Disorders (UCD) Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Urea Cycle Disorders (UCD) Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Urea Cycle Disorders (UCD) Treatment Market Value (USD Million) By Region

Table 10: Global Urea Cycle Disorders (UCD) Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Urea Cycle Disorders (UCD) Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Urea Cycle Disorders (UCD) Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Urea Cycle Disorders (UCD) Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Horizon Therapeutics Basic Information And Sales Area

Table 31: Horizon Therapeutics. Products Portfolio

Table 32: Eurocept BV Basic Information And Sales Area

Table 33: Eurocept BV. Products Portfolio

Table 34: Recordati Rare Diseases Inc. Basic Information And Sales Area

Table 35: Recordati Rare Diseases Inc.. Products Portfolio

Table 36: Synlogic Basic Information And Sales Area

Table 37: Synlogic. Products Portfolio

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Market Value (USD Million) (2025-2032) By Types

Table 41: Global Market Share (%) By Types (2032)

Table 42: Global Urea Cycle Disorders (UCD) Treatment Market Value (USD Million) By Region

Table 43: Global Urea Cycle Disorders (UCD) Treatment Market Share (%) By Region (2025-2032)

Table 44: North America Market Value (USD Million) (2025-2032) By Country

Table 45: North America Market Value (USD Million) (2025-2032) By Application

Table 46: North America Market Value (USD Million) (2025-2032) By Types

Table 47: Europe Market Value (USD Million) (2025-2032) By Country

Table 48: Europe Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Types

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 51: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 53: South America Market Value (USD Million) (2025-2032) By Country

Table 54: South America Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Types

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 57: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 59: Research Programs/Design For This Report

Table 60: Key Data Information From Secondary Sources

Table 61: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Urea Cycle Disorders (UCD) Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.44 billion
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Horizon Therapeutics; Eurocept BV; Recordati Rare Diseases Inc.; Synlogic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options